These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7113112)

  • 1. Febrile transfusion reaction: what blood component should be given next?
    Menitove JE; McElligott MC; Aster RH
    Vox Sang; 1982; 42(6):318-21. PubMed ID: 7113112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
    Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
    Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
    Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
    Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
    Yazer MH; Podlosky L; Clarke G; Nahirniak SM
    Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
    King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM
    Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012.
    Menis M; Forshee RA; Anderson SA; McKean S; Gondalia R; Warnock R; Johnson C; Mintz PD; Worrall CM; Kelman JA; Izurieta HS
    Vox Sang; 2015 Apr; 108(3):251-61. PubMed ID: 25470076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet antigens are associated with febrile non-hemolytic transfusion reactions.
    Chen DP; Wen YH; Lu JJ; Tseng CP; Chen WL; Chang SW
    Clin Chim Acta; 2017 Nov; 474():120-123. PubMed ID: 28919492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
    Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
    Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in circulating inflammatory markers following febrile non-haemolytic transfusion reactions to leucoreduced red cells.
    Larsen R; Sandhu N; Heegaard NHH; Ullum H; von Stemann JH; Sørensen E; Nellemann DS; Hansen MB
    Vox Sang; 2018 Jan; 113(1):76-79. PubMed ID: 29023768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febrile transfusion reaction: what blood component should be given next?
    Goldfinger D
    Vox Sang; 1983; 44(6):400-1. PubMed ID: 6880141
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of leukoreduction on the acute transfusion-related complication rate in 455 dogs receiving 730 packed RBCs: 2014-2017.
    Davidow EB; Montgomery H; Mensing M
    J Vet Emerg Crit Care (San Antonio); 2022 Jul; 32(4):479-490. PubMed ID: 35043550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
    Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
    Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress on febrile non-hemolytic transfusion reaction: a narrative review.
    Wang H; Ren D; Sun H; Liu J
    Ann Transl Med; 2022 Dec; 10(24):1401. PubMed ID: 36660666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microaggregate blood filtration and the febrile transfusion reaction. A comparative study.
    Wenz B
    Transfusion; 1983; 23(2):95-8. PubMed ID: 6836702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.
    Rajesh K; Harsh S; Amarjit K
    Ann Med Health Sci Res; 2015; 5(3):185-8. PubMed ID: 26097760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter.
    Sirchia G; Rebulla P; Parravicini A; Carnelli V; Gianotti GA; Bertolini F
    Transfusion; 1987; 27(5):402-5. PubMed ID: 3629670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients.
    Da Ponte A; Bidoli E; Talamini R; Steffan A; Abbruzzese L; Toffola RT; De Marco L
    Transfus Med; 2005 Feb; 15(1):37-43. PubMed ID: 15713127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions.
    Cohen R; Escorcia A; Tasmin F; Lima A; Lin Y; Lieberman L; Pendergrast J; Callum J; Cserti-Gazdewich C
    Transfusion; 2017 Jul; 57(7):1674-1683. PubMed ID: 28369916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Spin, cool, and filter' red cells prepared in a regional blood center.
    Callicoat PA; Hicks MW; Smith DM; Clark DA
    Transfusion; 1987; 27(4):332-4. PubMed ID: 3603662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal nocturnal hemoglobinuria and the transfusion of washed red cells. A myth revisited.
    Brecher ME; Taswell HF
    Transfusion; 1989 Oct; 29(8):681-5. PubMed ID: 2799892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.